Kenneth G Linden

Kenneth G Linden, MD, PhD, is a Professor at the University of California, Irvine (UCI) School of Medicine, with additional leadership roles as Director of Student Education and Chair of the UCI Institutional Review Board (IRB) for multiple divisions. His research focuses on dermatological oncology, particularly the diagnosis and treatment of rare skin cancers like Merkel cell carcinoma (MCC) and dermatofibrosarcoma protuberans (DFSP), including clinical trials on targeted therapies such as imatinib and immune checkpoint inhibitors. He is actively involved in medical education and institutional review processes.

Research Interests: His work spans the clinical management of nonmelanoma skin cancers, with an emphasis on immunotherapy applications (e.g., PD-1/PD-L1 inhibitors) and diagnostic challenges posed by nonspecific morphologies of tumors like MCC. He investigates survival outcomes, treatment efficacy, and diagnostic errors in rare dermatological conditions.